UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia

Leukemia, 2019-12, Vol.33 (12), p.2854-2866

2019

Volltextzugriff (PDF)

Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia

Blood cancer journal (New York), 2020-02, Vol.10 (2), p.15-15, Article 15

2020

Volltextzugriff (PDF)

Frequent occurrence of CD19-negative relapse after CD19 CAR T and consolidation therapy in 14 TP53-mutated r/r B-ALL children

Leukemia, 2020-12, Vol.34 (12), p.3382-3387

2020

Volltextzugriff (PDF)

Toxicity and effectiveness of CD19 CAR T therapy in children with high-burden central nervous system refractory B-ALL

Cancer Immunology, Immunotherapy, 2021-07, Vol.70 (7), p.1979-1993

2021

Volltextzugriff (PDF)

Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia

Journal of hematology and oncology, 2023-04, Vol.16 (1), p.34-34, Article 34

2023

Volltextzugriff (PDF)

C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trial

Nature communications, 2024-07, Vol.15 (1), p.6155-20, Article 6155

2024

Volltextzugriff (PDF)

Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy

BMC cancer, 2022-04, Vol.22 (1), p.393-393, Article 393

2022

Volltextzugriff (PDF)

Monocyte chemoattractant protein-1 secreted by decidual stromal cells inhibits NK cells cytotoxicity by up-regulating expression of SOCS3

PloS one, 2012-07, Vol.7 (7), p.e41869

2012

Volltextzugriff (PDF)

RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells

Gene, 2011-10, Vol.486 (1), p.74-80

2011

Volltextzugriff (PDF)

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial

Journal of clinical oncology, 2021-10, Vol.39 (30), p.3340-3351

2021

Volltextzugriff (PDF)

Sequential CD19-22 CAR T therapy induces sustained remission in children with r/r B-ALL

Blood, 2020-01, Vol.135 (5), p.387-391

2020

Volltextzugriff (PDF)

Ruxolitinib mitigates steroid‐refractory CRS during CAR T therapy

Journal of cellular and molecular medicine, 2021-01, Vol.25 (2), p.1089-1099

2021

Volltextzugriff (PDF)

Early response observed in pediatric patients with relapsed/refractory Burkitt lymphoma treated with chimeric antigen receptor T cells

Blood, 2020-06, Vol.135 (26), p.2425-2427

2020

Volltextzugriff (PDF)

Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma

Bone marrow transplantation (Basingstoke), 2023-04, Vol.58 (4), p.440-442

2023

Volltextzugriff (PDF)

Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study

The lancet oncology, 2023-11, Vol.24 (11), p.1229-1241

2023

Volltextzugriff (PDF)

Different protein profile in amniotic fluid with nervous system malformations by surface-enhanced laser desorption-ionization/time-of-flight mass spectrometry (SELDI-TOF-MS) technology

The journal of obstetrics and gynaecology research, 2010-12, Vol.36 (6), p.1195-1203

2010

Volltextzugriff (PDF)

Osteopontin Expression in Human Decidua is Associated with Decidual Natural Killer Cells Recruitment and Regulated by Progesterone

In vivo (Athens), 2008-01, Vol.22 (1), p.55-61

2008

Volltextzugriff (PDF)

Sequential different B-cell antigen–targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma

Blood advances, 2022-02, Vol.6 (3), p.717-730

2022

Volltextzugriff (PDF)

Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL

Blood advances, 2023-03, Vol.7 (6), p.1070-1075

2023

Volltextzugriff (PDF)

Biomarker discovery for ovarian cancer using SELDI-TOF-MS

Gynecologic oncology, 2006-07, Vol.102 (1), p.61-66

2006

Volltextzugriff (PDF)

Proteomic analysis reflects different histologic subtypes of epithelial ovarian cancer

Medical hypotheses, 2012-03, Vol.78 (3), p.407-409

2012

Volltextzugriff (PDF)

Combination of interferon-α and 5-fluorouracil induces apoptosis through mitochondrial pathway in hepatocellular carcinoma in vitro

Cancer letters, 2011-07, Vol.306 (1), p.34-42

2011

Volltextzugriff (PDF)

A novel full-human CD22-CAR T cell therapy with potent activity against CD22 low B-ALL

Blood cancer journal (New York), 2021-04, Vol.11 (4), p.71

2021

Volltextzugriff (PDF)

Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A

Cellular & molecular immunology, 2010-01, Vol.7 (1), p.77-82

2010

Volltextzugriff (PDF)

Effects of pretreatment protocols on human amniotic fluid protein profiling with SELDI-TOF MS using protein chips and magnetic beads

Clinica chimica acta, 2010-08, Vol.411 (15), p.1051-1057

2010

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)

Sprache

Englisch
(26)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(22)
Female
(17)
Child
(12)
Adult
(11)
Hematology
(11)
Oncology
(11)
Immunotherapy, Adoptive - Adverse Effects
(10)
Male
(9)
Lymphocytes T
(8)
Adolescent
(7)
Child, Preschool
(7)
Leukemia
(7)
Lymphocytes
(7)
Cd19 Antigen
(6)
Cytokines
(6)
Middle Aged
(6)
Neurotoxicity
(6)
Patients
(6)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia

Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia

Frequent occurrence of CD19-negative relapse after CD19 CAR T and consolidation therapy in 14 TP53-mutated r/r B-ALL children

Toxicity and effectiveness of CD19 CAR T therapy in children with high-burden central nervous system refractory B-ALL

Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia

C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trial

Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy

Monocyte chemoattractant protein-1 secreted by decidual stromal cells inhibits NK cells cytotoxicity by up-regulating expression of SOCS3

RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial

Sequential CD19-22 CAR T therapy induces sustained remission in children with r/r B-ALL

Ruxolitinib mitigates steroid‐refractory CRS during CAR T therapy

Early response observed in pediatric patients with relapsed/refractory Burkitt lymphoma treated with chimeric antigen receptor T cells

Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma

Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study

Different protein profile in amniotic fluid with nervous system malformations by surface-enhanced laser desorption-ionization/time-of-flight mass spectrometry (SELDI-TOF-MS) technology

Osteopontin Expression in Human Decidua is Associated with Decidual Natural Killer Cells Recruitment and Regulated by Progesterone

Sequential different B-cell antigen–targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma

Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL

Biomarker discovery for ovarian cancer using SELDI-TOF-MS

Proteomic analysis reflects different histologic subtypes of epithelial ovarian cancer

Combination of interferon-α and 5-fluorouracil induces apoptosis through mitochondrial pathway in hepatocellular carcinoma in vitro

A novel full-human CD22-CAR T cell therapy with potent activity against CD22 low B-ALL

Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A

Effects of pretreatment protocols on human amniotic fluid protein profiling with SELDI-TOF MS using protein chips and magnetic beads

Aktive Filter

Suchergebnisse filtern